SONX Sonendo, Inc.
Dental Equipment & Supplies · OTC · SEC CIK 1407973 · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-4.1%
TTM net income YoY54.0%
TTM EPS YoY54.5%
Revenue 3-yr CAGR0.0%
Net income 3-yr CAGR—
Margins
Gross margin35.7%
Operating margin-88.5%
Net margin-84.4%
FCF margin-74.7%
EBITDA margin-87.6%
Returns
ROE-166.8%
ROA-51.2%
ROIC (approx.)-75.8%
Asset turnover0.61x
Leverage & solvency
Liabilities / assets83.4%
Debt / equity2.78x
Current ratio1.39x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.88x
Accruals ratio-6.2%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $33.20M | $34.63M | $41.66M | $33.20M | $23.35M |
| Cost of revenue | $19.86M | $29.96M | $31.18M | $24.86M | $19.47M |
| Gross profit | $11.84M | $4.67M | $10.48M | $8.34M | $3.88M |
| R&D expense | $6.76M | $10.44M | $16.78M | $18.57M | $20.46M |
| SG&A expense | $17.35M | $24.79M | $51.91M | $33.91M | $26.70M |
| Operating income | -$29.37M | -$59.27M | -$58.20M | -$44.41M | -$42.80M |
| Interest expense | $5.47M | $6.46M | — | — | — |
| Pretax income | -$33.54M | -$62.46M | -$57.05M | -$48.50M | -$46.66M |
| Income tax | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Net income | -$28.03M | -$60.92M | -$57.05M | -$48.50M | -$46.66M |
| EBITDA | -$29.08M | -$58.15M | -$57.15M | -$42.98M | -$40.72M |
| EPS (basic) | -59.03 | -129.63 | -1.27 | -8.52 | -39.02 |
| EPS (diluted) | -59.03 | -129.63 | -1.27 | -8.52 | -39.02 |
| Weighted avg. shares (diluted) | 474,856 | 469,943 | 44.93M | 5.69M | 1.20M |
| Balance sheet | |||||
| Cash & equivalents | $10.23M | $14.01M | $17.66M | $84.64M | $51.72M |
| Short-term investments | $1.40M | $32.77M | $73.78M | — | — |
| Receivables | $3.68M | $4.79M | $5.80M | $2.52M | $1.93M |
| Inventory | $10.21M | $11.07M | $15.46M | $8.15M | $4.34M |
| Current assets | $27.80M | $65.27M | $121.11M | $98.86M | $58.90M |
| PP&E, net | $0 | $664,000 | $2.86M | $2.37M | $3.15M |
| Goodwill | — | $8.45M | $8.45M | $8.45M | $8.45M |
| Intangibles | — | $661,000 | $2.29M | $2.96M | $2.21M |
| Total assets | $31.27M | $78.16M | $137.28M | $115.50M | $76.14M |
| Current liabilities | $19.94M | $35.32M | $16.72M | $14.65M | $40.80M |
| Short-term debt | $10.80M | $24.90M | — | — | $28.35M |
| Long-term debt | $3.64M | $12.47M | $36.75M | $26.50M | — |
| Total debt | $14.44M | $37.37M | $36.75M | $26.50M | — |
| Total liabilities | $26.07M | $49.74M | $55.33M | $43.44M | $48.69M |
| Shareholders' equity | $5.19M | $28.42M | $81.95M | $72.06M | -$253.89M |
| Net debt | $4.21M | $23.36M | $19.08M | -$58.15M | — |
| Shares outstanding | 427,330 | 317,737 | 49.97M | 26.34M | 1.20M |
| Cash flow statement | |||||
| Operating cash flow | -$24.65M | -$46.06M | -$61.07M | -$48.60M | -$38.54M |
| Capital expenditure | $161,000 | $929,000 | $1.36M | $638,000 | $916,000 |
| Free cash flow | -$24.81M | -$46.99M | -$62.43M | -$49.24M | -$39.46M |
| Investing cash flow | $45.81M | $42.40M | -$74.43M | -$1.97M | -$916,000 |
| Financing cash flow | -$24.95M | $4,000 | $68.53M | $83.50M | -$983,000 |
| Depreciation & amortization | $288,000 | $1.12M | $1.05M | $1.43M | $2.08M |
| Stock-based compensation | $4.82M | $7.28M | $7.48M | $2.37M | $1.64M |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.